Kingwell, Bronwyn A.
Chapman, M. John
Kontush, Anatol
Miller, Norman E.
Article History
First Online: 23 May 2014
Competing interests
: B.A.K. has received product funding (but no research funding) from CSL and patient plasma (but no research funding) from Hoffman La Roche, both for investigator-initiated clinical trials. She has also partnered with Resverlogix to jointly fund an investigator-initiated trial. M.J.C. and A.K. have received research grant funding from CSL. N.E.M. has no disclosures.